{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:11:13Z","timestamp":1760083873092,"version":"build-2065373602"},"reference-count":114,"publisher":"Jaypee Brothers Medical Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.59556\/japi.73.1050","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:27:50Z","timestamp":1760081270000},"page":"79-87","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of Cardiac Amyloidosis in South Asia: Need for a Collaborative Approach from Researchers and Clinicians"],"prefix":"10.59556","volume":"73","author":[{"given":"Shreya","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dibbendhu","family":"Khanra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayanika","family":"Kala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani Kumar","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"key":"key20251010072744_B1","doi-asserted-by":"crossref","unstructured":"Rubin J, Maurer MS. Cardiac amyloidosis: overlooked, underappreciated, and treatable. Annu Rev Med 2020;71:203\u2013219.","DOI":"10.1146\/annurev-med-052918-020140"},{"key":"key20251010072744_B2","doi-asserted-by":"crossref","first-page":"1046\u2013","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data.","volume":"2:","author":"Quock","year":"2018;","journal-title":"Blood Adv"},{"issue":"(10):","key":"key20251010072744_B3","doi-asserted-by":"crossref","first-page":"e339.","DOI":"10.1016\/j.clml.2019.09.558","article-title":"Estimating the global epidemiology of amyloid light-chain amyloidosis with an incidence-to-prevalence model.","volume":"19","author":"Zhang","year":"2019;","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"(8):","key":"key20251010072744_B4","doi-asserted-by":"crossref","first-page":"S73.","DOI":"10.1016\/j.cardfail.2017.07.207","article-title":"Estimating population-level prevalence of wild-type and variant transthyretin amyloid cardiomyopathy.","volume":"23","author":"Grogan","year":"2017;","journal-title":"J Card Fail"},{"issue":"(25):","key":"key20251010072744_B5","doi-asserted-by":"crossref","first-page":"2982\u2013","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study.","volume":"76","author":"Roth","year":"2020;","journal-title":"J Am College Cardiol"},{"issue":"(4):","key":"key20251010072744_B6","first-page":"611\u2013","article-title":"Management of amyloid cardiomyopathy in resource-constrained settings: challenges and opportunities.","volume":"3","author":"Singh","year":"2021;","journal-title":"Cardio Oncol"},{"issue":"(12):","key":"key20251010072744_B7","first-page":"e178\u2013","article-title":"Cardiac amyloidosis.","volume":"126","author":"Quarta","year":"2012;","journal-title":"Circulation"},{"issue":"(1):","key":"key20251010072744_B8","doi-asserted-by":"crossref","first-page":"221.","DOI":"10.1186\/s12872-018-0952-8","article-title":"Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.","volume":"18","author":"Kyriakou","year":"2018;","journal-title":"BMC Cardiovasc Disord"},{"issue":"(10038):","key":"key20251010072744_B9","doi-asserted-by":"crossref","first-page":"2641\u2013","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis.","volume":"387","author":"Wechalekar","year":"2016;","journal-title":"Lancet"},{"issue":"(2):","key":"key20251010072744_B10","doi-asserted-by":"crossref","first-page":"113\u2013","DOI":"10.15420\/ecr.2015.10.2.113","article-title":"Cardiac amyloid\u2014an update.","volume":"10","author":"Dungu","year":"2015;","journal-title":"Eur Cardiol Rev"},{"issue":"(12):","key":"key20251010072744_B11","doi-asserted-by":"crossref","first-page":"1323\u2013","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy.","volume":"68","author":"Falk","year":"2016;","journal-title":"J Am Coll Cardiol"},{"issue":"(2):","key":"key20251010072744_B12","doi-asserted-by":"crossref","first-page":"157\u2013","DOI":"10.1111\/anec.12018","article-title":"The findings of electrocardiography in patients with cardiac amyloidosis.","volume":"18","author":"Cheng","year":"2013;","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"(2):","key":"key20251010072744_B13","doi-asserted-by":"crossref","first-page":"e000881.","DOI":"10.1136\/openhrt-2018-000881","article-title":"Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis.","volume":"5","author":"Agha","year":"2018;","journal-title":"Open Heart"},{"issue":"(3):","key":"key20251010072744_B14","doi-asserted-by":"crossref","first-page":"808\u2013","DOI":"10.1161\/01.CIR.83.3.808","article-title":"Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. a Doppler echocardiography study.","volume":"83","author":"Klein","year":"1991;","journal-title":"Circulation"},{"issue":"(3):","key":"key20251010072744_B15","first-page":"e005588.","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters.","volume":"10","author":"Pagourelias","year":"2017;","journal-title":"Circ Cardiovasc Imaging"},{"issue":"(9):","key":"key20251010072744_B16","first-page":"1\u2013","article-title":"Cardiac amyloidosis: updates in imaging.","volume":"21","author":"Chacko","year":"2019;","journal-title":"Curr Cardiol Rep"},{"issue":"(5):","key":"key20251010072744_B17","first-page":"1\u2013","article-title":"Advances in the treatment of cardiac amyloidosis.","volume":"21","author":"Macedo","year":"2020;","journal-title":"Curr Treat Options Oncol"},{"issue":"(16):","key":"key20251010072744_B18","doi-asserted-by":"crossref","first-page":"1570\u2013","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis.","volume":"132","author":"Fontana","year":"2015;","journal-title":"Circulation"},{"issue":"(22):","key":"key20251010072744_B19","doi-asserted-by":"crossref","first-page":"2872\u2013","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review.","volume":"73","author":"Ruberg","year":"2019;","journal-title":"J Am Coll Cardiol"},{"issue":"(6):","key":"key20251010072744_B20","doi-asserted-by":"crossref","first-page":"1076\u2013","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy.","volume":"46","author":"Perugini","year":"2005;","journal-title":"J Am Coll Cardiol"},{"issue":"(2):","key":"key20251010072744_B21","doi-asserted-by":"crossref","first-page":"195\u2013","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.","volume":"6","author":"Bokhari","year":"2013;","journal-title":"Circ Cardiovasc Imaging"},{"issue":"(8):","key":"key20251010072744_B22","doi-asserted-by":"crossref","first-page":"880\u2013","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis.","volume":"1","author":"Castano","year":"2016;","journal-title":"JAMA Cardiol"},{"issue":"(1):","key":"key20251010072744_B23","doi-asserted-by":"crossref","first-page":"158\u2013","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.","volume":"26","author":"Singh","year":"2019;","journal-title":"J Nucl Cardiol"},{"issue":"(6):","key":"key20251010072744_B24","doi-asserted-by":"crossref","first-page":"1827\u2013","DOI":"10.3748\/wjg.v21.i6.1827","article-title":"Digitally reinforced hematoxylin-eosin polarization technique in diagnosis of rectal amyloidosis.","volume":"21","author":"Doganavsargil","year":"2015;","journal-title":"World J Gastroenterol"},{"issue":"(3):","key":"key20251010072744_B25","doi-asserted-by":"crossref","first-page":"232\u2013","DOI":"10.1038\/labinvest.3700714","article-title":"Physical basis of colors seen in Congo red-stained amyloid in polarized light.","volume":"88","author":"Howie","year":"2008;","journal-title":"Lab Invest"},{"issue":"(3):","key":"key20251010072744_B26","doi-asserted-by":"crossref","first-page":"285\u2013","DOI":"10.1016\/j.micron.2008.10.002","article-title":"Optical properties of amyloid stained by Congo red: history and mechanisms.","volume":"40","author":"Howie","year":"2009;","journal-title":"Micron"},{"volume-title":"\u201cAmyloid\u201d\u2014Historical Aspects. Amyloidosis.","year":"2013.","author":"Tanskanen","key":"key20251010072744_B27"},{"issue":"(2):","key":"key20251010072744_B28","doi-asserted-by":"crossref","first-page":"s30\u2013","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis.","volume":"18","author":"Martinez-Naharro","year":"2018;","journal-title":"Clin Med"},{"issue":"(4):","key":"key20251010072744_B29","doi-asserted-by":"crossref","first-page":"314\u2013","DOI":"10.1136\/jclinpath-2014-202722","article-title":"A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.","volume":"68","author":"Gilbertson","year":"2015;","journal-title":"J Clin Pathol"},{"issue":"(2):","key":"key20251010072744_B30","doi-asserted-by":"crossref","first-page":"331\u2013","DOI":"10.1016\/j.kint.2021.10.017","article-title":"RNA-based immunoglobulin repertoire sequencing is a new tool for the management of monoclonal gammopathy of renal (kidney) significance.","volume":"101","author":"Javaugue","year":"2022;","journal-title":"Kidney Int"},{"issue":"(5):","key":"key20251010072744_B31","doi-asserted-by":"crossref","first-page":"413\u2013","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis.","volume":"25","author":"Stats","year":"2016;","journal-title":"Cardiovasc Pathol"},{"issue":"(6):","key":"key20251010072744_B32","doi-asserted-by":"crossref","first-page":"705\u2013","DOI":"10.1016\/j.radcr.2020.03.010","article-title":"Incidentally detected cardiac amyloidosis on 99mTc-MDP bone scintigraphy.","volume":"15","author":"Fathala","year":"2020;","journal-title":"Radiol Case Rep"},{"issue":"(5):","key":"key20251010072744_B33","doi-asserted-by":"crossref","first-page":"1559\u2013","DOI":"10.1007\/s12350-017-0799-x","article-title":"18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis.","volume":"25","author":"Morgenstern","year":"2018;","journal-title":"J Nucl Cardiol"},{"key":"key20251010072744_B34","doi-asserted-by":"crossref","first-page":"1095-","DOI":"10.1007\/s00259-013-2375-1","article-title":"Utility of 18 F-FDG PET (\/CT) in patients with systemic and localized amyloidosis.","volume":"40:","author":"Glaudemans","year":"2013;","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"(1):","key":"key20251010072744_B35","doi-asserted-by":"crossref","first-page":"246\u2013","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions.","volume":"14","author":"Genovesi","year":"2021;","journal-title":"JACC Cardiovasc Imaging"},{"issue":"(6):","key":"key20251010072744_B36","doi-asserted-by":"crossref","first-page":"1337\u2013","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic accuracy of [11C]PIB positron emission tomography for detection of cardiac amyloidosis.","volume":"13","author":"Rosengren","year":"2020;","journal-title":"JACC Cardiovasc Imaging"},{"issue":"(9):","key":"key20251010072744_B37","doi-asserted-by":"crossref","first-page":"1652\u2013","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography.","volume":"41","author":"Dorbala","year":"2014;","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"(8):","key":"key20251010072744_B38","doi-asserted-by":"crossref","first-page":"624\u2013","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography.","volume":"33","author":"Dietemann","year":"2019;","journal-title":"Ann Nucl Med"},{"key":"key20251010072744_B39","doi-asserted-by":"crossref","first-page":"1003.","DOI":"10.1182\/blood-2018-99-118177","article-title":"Personalizing amyloidosis therapy with real time PET imaging of fibril-reactive monoclonal antibody cael-101.","volume":"132:","author":"Fu","year":"2018;","journal-title":"Blood"},{"issue":"(12):","key":"key20251010072744_B40","doi-asserted-by":"crossref","first-page":"e52686.","DOI":"10.1371\/journal.pone.0052686","article-title":"AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.","volume":"7","author":"Wall","year":"2012;","journal-title":"PLoS One"},{"key":"key20251010072744_B41","first-page":"1702.","article-title":"Clinical utility of PET\/CT imaging with peptide imaging agent 124I-p5+14 (AT-01) in patients with systemic amyloidosis.","volume":"62:","author":"Wall","year":"2021;","journal-title":"J Nucl Med"},{"issue":"(46):","key":"key20251010072744_B42","first-page":"E10839\u2013","article-title":"Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.","volume":"115","author":"Wall","year":"2018;","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(2):","key":"key20251010072744_B43","doi-asserted-by":"crossref","first-page":"409\u2013","DOI":"10.1016\/j.hfc.2016.12.003","article-title":"Current concepts of cardiac amyloidosis: diagnosis, clinical management, and the need for collaboration.","volume":"13","author":"Ritts","year":"2017;","journal-title":"Heart Fail Clin"},{"issue":"(4):","key":"key20251010072744_B44","first-page":"343\u2013","article-title":"Cardiac care of patients with cardiac amyloidosis.","volume":"143","author":"Zadok","year":"2020;","journal-title":"Acta Haematol"},{"issue":"(4):","key":"key20251010072744_B45","doi-asserted-by":"crossref","first-page":"351\u2013","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac amyloidosis.","volume":"6","author":"Giancaterino","year":"2020;","journal-title":"JACC Clin Electrophysiol"},{"issue":"(5):","key":"key20251010072744_B46","doi-asserted-by":"crossref","first-page":"541\u2013","DOI":"10.1136\/hrt.74.5.541","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.","volume":"74","author":"Dubrey","year":"1995;","journal-title":"Br Heart J"},{"issue":"(4):","key":"key20251010072744_B47","doi-asserted-by":"crossref","first-page":"352\u2013","DOI":"10.1159\/000508262","article-title":"Solid organ transplantation in amyloidosis.","volume":"143","author":"Theodorakakou","year":"2020;","journal-title":"Acta Haematol"},{"issue":"(4):","key":"key20251010072744_B48","doi-asserted-by":"crossref","first-page":"324\u2013","DOI":"10.1212\/WNL.0b013e3181ea15d4","article-title":"Progression of transthyretin amyloid neuropathy after liver transplantation.","volume":"75","author":"Liepnieks","year":"2010;","journal-title":"Neurology"},{"issue":"(8):","key":"key20251010072744_B49","doi-asserted-by":"crossref","first-page":"S81.","DOI":"10.1016\/j.cardfail.2018.07.326","article-title":"Progressive cardiomyopathy in TTR amyloidosis after liver transplant.","volume":"24","author":"Kay","year":"2018;","journal-title":"J Card Fail"},{"issue":"(5):","key":"key20251010072744_B50","doi-asserted-by":"crossref","first-page":"745\u2013","DOI":"10.1097\/00007890-200203150-00015","article-title":"Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.","volume":"73","author":"Olofsson","year":"2002;","journal-title":"Transplantation"},{"issue":"(4):","key":"key20251010072744_B51","doi-asserted-by":"crossref","first-page":"976\u2013","DOI":"10.1007\/s00415-017-8708-4","article-title":"Transthyretin familial amyloid polyneuropathy: an update.","volume":"265","author":"Plante-Bordeneuve","year":"2018;","journal-title":"J Neurol"},{"issue":"(3):","key":"key20251010072744_B52","doi-asserted-by":"crossref","first-page":"282\u2013","DOI":"10.1002\/lt.24058","article-title":"Liver transplantation in transthyretin amyloidosis: issues and challenges.","volume":"21","author":"Carvalho","year":"2015;","journal-title":"Liver Transpl"},{"key":"key20251010072744_B53","doi-asserted-by":"crossref","first-page":"115\u2013","DOI":"10.1111\/ajt.13670","article-title":"Heart.","volume":"16:","author":"Colvin","year":"2016;","journal-title":"Am J Transplant"},{"issue":"(3):","key":"key20251010072744_B54","doi-asserted-by":"crossref","first-page":"317\u2013","DOI":"10.1007\/s10741-017-9601-z","article-title":"Heart transplantation in cardiac amyloidosis.","volume":"22","author":"Sousa","year":"2017;","journal-title":"Heart Fail Rev"},{"issue":"(11):","key":"key20251010072744_B55","doi-asserted-by":"crossref","first-page":"2256\u2013","DOI":"10.1097\/TP.0000000000004230","article-title":"Clinical outcomes and effectiveness of heart transplantation in patients with systemic light-chain cardiac amyloidosis.","volume":"106","author":"Jeong","year":"2022;","journal-title":"Transplantation"},{"issue":"(6):","key":"key20251010072744_B56","doi-asserted-by":"crossref","first-page":"461\u2013","DOI":"10.1016\/j.jchf.2019.12.013","article-title":"Outcomes in patients with cardiac amyloidosis undergoing heart transplantation.","volume":"8","author":"Barrett","year":"2020;","journal-title":"JACC Heart Fail"},{"issue":"(10):","key":"key20251010072744_B57","doi-asserted-by":"crossref","first-page":"2900\u2013","DOI":"10.1111\/ajt.15487","article-title":"Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis.","volume":"19","author":"Trachtenberg","year":"2019;","journal-title":"Am J Transplant"},{"issue":"(8):","key":"key20251010072744_B58","doi-asserted-by":"crossref","first-page":"575\u2013","DOI":"10.1038\/d41573-019-00121-9","article-title":"FDA new drug approvals in Q2 2019.","volume":"18","author":"Urquhart","year":"2019;","journal-title":"Nat Rev Drug Discov"},{"key":"key20251010072744_B59","doi-asserted-by":"crossref","DOI":"10.31525\/fda2-ucm616518.htm","volume-title":"FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease.","author":"US Food and Drug Administration.","year":"2018."},{"key":"key20251010072744_B60","doi-asserted-by":"crossref","first-page":"1419\u2013","DOI":"10.1007\/s40265-022-01765-5","article-title":"Vutrisiran: first approval.","volume":"82:","author":"Keam","year":"2022;","journal-title":"Drugs"},{"issue":"(13):","key":"key20251010072744_B61","doi-asserted-by":"crossref","first-page":"1371\u2013","DOI":"10.1007\/s40265-018-0968-5","article-title":"Inotersen: first global approval.","volume":"78","author":"Keam","year":"2018;","journal-title":"Drugs"},{"issue":"(13):","key":"key20251010072744_B62","doi-asserted-by":"crossref","first-page":"9010\u2013","DOI":"10.1021\/acs.jmedchem.1c00099","article-title":"Identification of transthyretin tetramer kinetic stabilizers that are capable of inhibiting the retinol-dependent retinol binding protein 4-transthyretin interaction: potential novel therapeutics for macular degeneration, transthyretin amyloidosis, and their common age-related comorbidities.","volume":"64","author":"Cioffi","year":"2021;","journal-title":"J Med Chem"},{"issue":"(15):","key":"key20251010072744_B63","doi-asserted-by":"crossref","first-page":"6130\u2013","DOI":"10.1074\/jbc.RA118.005257","article-title":"A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils.","volume":"294","author":"Saelices","year":"2019;","journal-title":"J Biol Chem"},{"key":"key20251010072744_B64","doi-asserted-by":"crossref","first-page":"118\u2013","DOI":"10.1016\/j.nbd.2018.09.007","article-title":"Assessment of the effects of transthyretin peptide inhibitors in Drosophila models of neuropathic ATTR.","volume":"120:","author":"Saelices","year":"2018;","journal-title":"Neurobiol Dis"},{"issue":"(422):","key":"key20251010072744_B65","doi-asserted-by":"crossref","first-page":"eaan3128.","DOI":"10.1126\/scitranslmed.aan3128","article-title":"Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.","volume":"10","author":"Richards","year":"2018;","journal-title":"Sci Transl Med"},{"key":"key20251010072744_B66","first-page":"140\u2013","article-title":"Revlimid (lenalidomide) now FDA approved as first-line therapy for patients with multiple myeloma.","volume":"9:","author":"Raedler","year":"2016;","journal-title":"Am Health Drug Benefits"},{"issue":"(1):","key":"key20251010072744_B67","doi-asserted-by":"crossref","first-page":"89\u2013","DOI":"10.1007\/s00277-011-1244-x","article-title":"Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.","volume":"91","author":"Palladini","year":"2012;","journal-title":"Ann Hematol"},{"issue":"(4):","key":"key20251010072744_B68","doi-asserted-by":"crossref","first-page":"234\u2013","DOI":"10.1080\/13506129.2018.1540410","article-title":"Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis.","volume":"25","author":"Kastritis","year":"2018;","journal-title":"Amyloid"},{"issue":"(5):","key":"key20251010072744_B69","first-page":"1\u2013","article-title":"Venetoclax for the treatment of translocation (11;14) AL amyloidosis.","volume":"10","author":"Sidiqi","year":"2020;","journal-title":"Blood Cancer J"},{"issue":"(19):","key":"key20251010072744_B70","doi-asserted-by":"crossref","first-page":"4391\u2013","DOI":"10.1182\/blood-2011-11-390930","article-title":"Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.","volume":"119","author":"Mikhael","year":"2012;","journal-title":"Blood"},{"issue":"(12):","key":"key20251010072744_B71","doi-asserted-by":"crossref","first-page":"1629.","DOI":"10.3390\/cells8121629","article-title":"The anti-CD38 antibody therapy in multiple myeloma.","volume":"8","author":"Petrucci","year":"2019;","journal-title":"Cells"},{"issue":"(1):","key":"key20251010072744_B72","first-page":"1\u2013","volume":"9","author":"Sanchez","year":"2016;","journal-title":"Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myelomaJ Hematol Oncol."},{"article-title":"FDA grants accelerated approval to Darzalex Faspro for newly diagnosed light chain amyloidosis.","year":"2021.","author":"US Food and Drug Administration.","key":"key20251010072744_B73"},{"issue":"(3):","key":"key20251010072744_B74","doi-asserted-by":"crossref","first-page":"168\u2013","DOI":"10.1080\/13506129.2016.1205974","article-title":"2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis.","volume":"23","author":"Renz","year":"2016;","journal-title":"Amyloid"},{"issue":"(1):","key":"key20251010072744_B75","doi-asserted-by":"crossref","first-page":"115\u2013","DOI":"10.1080\/13506129.2019.1584892","article-title":"One year follow up analysis of the phase 1a\/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.","volume":"26","author":"Edwards","year":"2019;","journal-title":"Amyloid"},{"key":"key20251010072744_B76","doi-asserted-by":"crossref","first-page":"1207.","DOI":"10.1182\/blood-2021-151908","article-title":"Pre-clinical characterization of a novel fusion protein (AT-03), with pan-amyloid binding and removal.","volume":"138:","author":"Sirac","year":"2021;","journal-title":"Blood"},{"issue":"(3):","key":"key20251010072744_B77","doi-asserted-by":"crossref","first-page":"131\u2013","DOI":"10.4103\/0973-1075.121520","article-title":"Significance of the development of a cardiovascular disease surveillance and reporting system in India.","volume":"19","author":"Coelho","year":"2013;","journal-title":"Indian J Palliat Care"},{"issue":"(1):","key":"key20251010072744_B78","doi-asserted-by":"crossref","first-page":"1\u2013","DOI":"10.1016\/j.jacasi.2021.04.007","article-title":"Epidemiological features of cardiovascular disease in Asia.","volume":"1","author":"Zhao","year":"2021;","journal-title":"JACC Asia"},{"issue":"(996):","key":"key20251010072744_B79","doi-asserted-by":"crossref","first-page":"518\u2013","DOI":"10.1136\/pgmj.2007.066381","article-title":"Cardiovascular risk in South Asians.","volume":"84","author":"Ramaraj","year":"2008;","journal-title":"Postgrad Med J"},{"key":"key20251010072744_B80","first-page":"786801.","article-title":"Assessment of cardiovascular disease risk in South Asian populations.","volume":"2013:","author":"Hussain","year":"2013;","journal-title":"Int J Vasc Med"},{"issue":"(10111):","key":"key20251010072744_B81","doi-asserted-by":"crossref","first-page":"2437\u2013","DOI":"10.1016\/S0140-6736(17)32804-0","article-title":"Nations within a nation: variations in epidemiological transition across the states of India 1990\u20132016 in the global burden of disease study.","volume":"390","author":"Dandona","year":"2017;","journal-title":"Lancet"},{"issue":"(9498):","key":"key20251010072744_B82","doi-asserted-by":"crossref","first-page":"1744\u2013","DOI":"10.1016\/S0140-6736(05)67343-6","article-title":"Responding to the threat of chronic diseases in India.","volume":"366","author":"Reddy","year":"2005;","journal-title":"Lancet"},{"issue":"(12):","key":"key20251010072744_B83","doi-asserted-by":"crossref","first-page":"e1339\u2013","DOI":"10.1016\/S2214-109X(18)30407-8","article-title":"The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990\u20132016.","volume":"6","author":"Prabhakaran","year":"2018;","journal-title":"Lancet Glob Health"},{"key":"key20251010072744_B84","first-page":"100602.","article-title":"Cardiovascular disease trends in Nepal\u2014an analysis of global burden of disease data 2017.","volume":"30:","author":"Bhattarai","year":"2020;","journal-title":"Int J Cardiol Heart Vasc"},{"key":"key20251010072744_B85","doi-asserted-by":"crossref","first-page":"11\u2013","DOI":"10.4038\/cmj.v61i1.8253","article-title":"Risk estimates of cardiovascular diseases in a Sri Lankan community.","volume":"61:","author":"Ranawaka","year":"2016;","journal-title":"Ceylon Med J"},{"key":"key20251010072744_B86","doi-asserted-by":"crossref","first-page":"165\u2013","DOI":"10.2147\/VHRM.S166111","article-title":"Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies.","volume":"14:","author":"Chowdhury","year":"2018;","journal-title":"Vasc Health Risk Manag"},{"issue":"(2):","key":"key20251010072744_B87","doi-asserted-by":"crossref","first-page":"173\u2013","DOI":"10.3329\/jdmc.v26i2.38839","article-title":"An unusual cause of generalized swelling.","volume":"26","author":"Shahrin","year":"2018;","journal-title":"J Dhaka Med Coll"},{"issue":"(1).","key":"key20251010072744_B88","article-title":"Renal amyloidosis in Pakistan.","volume":"13","author":"Ali","year":"2011;","journal-title":"J Postgrad Med Inst"},{"issue":"(663):","key":"key20251010072744_B89","doi-asserted-by":"crossref","first-page":"31\u2013","DOI":"10.1136\/pgmj.57.663.31","article-title":"Pattern of renal amyloidosis in Indian patients.","volume":"57","author":"Chugh","year":"1981;","journal-title":"Postgrad Med J"},{"issue":"(5):","key":"key20251010072744_B90","doi-asserted-by":"crossref","first-page":"1065\u2013","DOI":"10.4103\/1319-2442.243966","article-title":"Clinical and laboratory profile of renal amyloidosis: a single-center experience.","volume":"29","author":"Engineer","year":"2018;","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"(6):","key":"key20251010072744_B91","first-page":"407\u2013","article-title":"Pattern of renal amyloidosis in western India. A study of 104 cases.","volume":"38","author":"Mehta","year":"1990;","journal-title":"J Assoc Physicians India"},{"issue":"(4):","key":"key20251010072744_B92","doi-asserted-by":"crossref","first-page":"189\u2013","DOI":"10.4038\/cmj.v61i4.8388","article-title":"Pathological characteristics of fifty patients with renal amyloidosis in Sri Lanka.","volume":"61","author":"Dasanayaka","year":"2016;","journal-title":"Ceylon Med J"},{"issue":"(2):","key":"key20251010072744_B93","doi-asserted-by":"crossref","first-page":"61.","DOI":"10.4236\/ojneph.2015.52010","article-title":"Experience of percutaneus kidney biopsy from a tertiary care center of Pakistan.","volume":"5","author":"Absar","year":"2015;","journal-title":"Open J Nephrol"},{"issue":"(4):","key":"key20251010072744_B94","doi-asserted-by":"crossref","first-page":"842.","DOI":"10.4103\/0377-4929.72077","article-title":"Cardiac amyloidosis: report of an autopsy case with review of the literature.","volume":"53","author":"Mysorekar","year":"2010;","journal-title":"Indian J Pathol Microbiol"},{"issue":"(2):","key":"key20251010072744_B95","doi-asserted-by":"crossref","first-page":"106.","DOI":"10.4103\/0971-4065.135911","article-title":"Heavy and light chain amyloidosis presenting as complete heart block: a rare presentation of a rare disease.","volume":"25","author":"Priyamvada","year":"2015;","journal-title":"Indian J Nephrol"},{"issue":"(8):","key":"key20251010072744_B96","first-page":"35\u2013","article-title":"Cardiac amyloidosis: a case series from India.","volume":"67","author":"Raut","year":"2019;","journal-title":"J Assoc Physicians India"},{"issue":"(17):","key":"key20251010072744_B97","doi-asserted-by":"crossref","first-page":"e25462.","DOI":"10.1097\/MD.0000000000025462","article-title":"Wild type transthyretin cardiac amyloidosis in a young individual: a case report.","volume":"100","author":"Ghosh","year":"2021;","journal-title":"Medicine"},{"issue":"(10):","key":"key20251010072744_B98","first-page":"e007218.","article-title":"The upcoming epidemic of heart failure in South Asia.","volume":"13","author":"Martinez-Amezcua","year":"2020;","journal-title":"Circ Heart Fail"},{"issue":"(11):","key":"key20251010072744_B99","doi-asserted-by":"crossref","first-page":"967\u2013","DOI":"10.1016\/j.tim.2021.03.008","article-title":"Likelihood of amyloid formation in COVID-19-induced ARDS.","volume":"29","author":"Sinha","year":"2021;","journal-title":"Trends Microbiol"},{"issue":"(3):","key":"key20251010072744_B100","doi-asserted-by":"crossref","first-page":"346\u2013","DOI":"10.1111\/bjh.16898","article-title":"Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.","volume":"190","author":"Kastritis","year":"2020;","journal-title":"Br J Haematol"},{"issue":"(1):","key":"key20251010072744_B101","first-page":"1\u2013","article-title":"ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.","volume":"16","author":"Brannagan","year":"2021;","journal-title":"Orphanet J Rare Dis"},{"issue":"(23):","key":"key20251010072744_B102","doi-asserted-by":"crossref","first-page":"2033\u2013","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation.","volume":"135","author":"Connors","year":"2020;","journal-title":"Blood"},{"issue":"(21):","key":"key20251010072744_B103","doi-asserted-by":"crossref","first-page":"2451\u2013","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis.","volume":"66","author":"Gertz","year":"2015;","journal-title":"J Am Coll Cardiol"},{"issue":"(5):","key":"key20251010072744_B104","doi-asserted-by":"crossref","first-page":"589\u2013","DOI":"10.1016\/j.jacc.2018.10.079","article-title":"Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis.","volume":"73","author":"El-Am","year":"2019;","journal-title":"J Am Coll Cardiol"},{"issue":"(20):","key":"key20251010072744_B105","doi-asserted-by":"crossref","first-page":"1648\u2013","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease.","volume":"141","author":"Clerkin","year":"2020;","journal-title":"Circulation"},{"issue":"(10):","key":"key20251010072744_B106","doi-asserted-by":"crossref","first-page":"1443\u2013","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the heart.","volume":"126","author":"Akhmerov","year":"2020;","journal-title":"Circ Res"},{"issue":"(3):","key":"key20251010072744_B107","doi-asserted-by":"crossref","first-page":"230\u2013","DOI":"10.1161\/CIRCULATIONAHA.120.050754","article-title":"COVID-19-associated nonocclusive fibrin microthrombi in the heart.","volume":"143","author":"Bois","year":"2021;","journal-title":"Circulation"},{"volume-title":"COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers.","year":"2020.","author":"World Health Organization.","key":"key20251010072744_B108"},{"issue":"(6):","key":"key20251010072744_B109","doi-asserted-by":"crossref","first-page":"1900\u2013","DOI":"10.1002\/hep.31574","article-title":"Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID-19): U.S. multicenter experience.","volume":"72","author":"Rabiee","year":"2020;","journal-title":"Hepatology"},{"key":"key20251010072744_B110","doi-asserted-by":"crossref","first-page":"169\u2013","DOI":"10.1016\/j.ijid.2020.12.048","article-title":"Pandemic preparedness and response to COVID-19 in South Asian countries.","volume":"104:","author":"Babu","year":"2021;","journal-title":"Int J Infec Dis"},{"issue":"(4):","key":"key20251010072744_B111","doi-asserted-by":"crossref","first-page":"479\u2013","DOI":"10.1007\/s00392-020-01799-3","article-title":"Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).","volume":"110","author":"Yilmaz","year":"2021;","journal-title":"Clin Res Cardiol"},{"issue":"(1):","key":"key20251010072744_B112","first-page":"1\u2013","article-title":"Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy.","volume":"14","author":"He","year":"2019;","journal-title":"Orphanet J Rare Dis"},{"issue":"(5):","key":"key20251010072744_B113","first-page":"221\u2013","article-title":"A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.","volume":"22","author":"Ono","year":"2020;","journal-title":"J Cardiol Cases"},{"issue":"(3):","key":"key20251010072744_B114","doi-asserted-by":"crossref","first-page":"160\u2013","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003.","volume":"10","author":"Connors","year":"2003;","journal-title":"Amyloid"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:28:07Z","timestamp":1760081287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-7-79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":114,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.59556\/japi.73.1050"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.1050","relation":{},"ISSN":["0004-5772"],"issn-type":[{"type":"print","value":"0004-5772"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}